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Diabetes mellitus is a chronic disease resulting in oxidative stress that promotes tissue damage. The 
appearance of this disease is highly related to lifestyle and food of the population, being of great interest 
to search for a dietary supplement that can also act by reducing oxidative alterations. Based on the broad 
range of biological activity of thiazole derivatives, this work aimed to evaluate the in vitro antioxidant 
activity of a novel hydrazine-thiazole derivative and studies in vivo. In in vivo experiments, the liver 
extracts of healthy and diabetic Wistar rats were used, with analysis to determine the enzymatic activity of 
SOD, CAT, GPx, and GR, and determination of lipid peroxidation. Finally, in the blood of these animals, 
biochemical parameters were evaluated. Statistical evidence of changes caused in liver enzymes and 
liquid peroxidation was not detected; however, these parameters were also not changed between control 
groups with and without diabetes. On the other hand, concerning biochemical parameters, significant 
differences were detected in uric acid, alkaline phosphatase, ALT, and urea, indicating a possible 
antioxidant protective role of such substances in the liver and kidney of diabetic animals that could be 
acting by means other than that commonly reported in the literature.
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INTRODUCTION 
Human organism,  by means of  i ts  normal 
biochemical functions, continuously produces reactive 
species, against which there is an antioxidant defense 
system. However, when there is an imbalance, either by 
increased production of these reactive species or from a 
decrease in the defense network, a condition known as to 
oxidative stress is installed. Under such condition, reactive 
species generate cumulative damage to biomolecules 
such as lipids, proteins and DNA, being related to several 
chronic diseases, for example diabetes mellitus (Carocho, 
Ferreira, 2013; Yadav et al., 2013; Rani et al., 2016).
Diabetes mellitus (DM) is a metabolic disorder 
characterized by chronic hyperglycemia, affecting the 
oxidative stress associated metabolism, which leads to 
serious health problems. The increasing number of such 
disease in world population, assigned not only to the 
increasing number of elderly, but mainly to the current 
lifestyle, causes diabetes to have a major impact on 
health expenditures. It is therefore important to control 
the worsening of such disease in order to both reduce the 
suffering of patients and contain social costs (Henriques 
et al., 2010; WHO, 2016).
Thus, in recent years, it has grown the interest 
for antioxidant compounds naturally present in food or 
synthesized from them, that are effective in preventing the 
onset or worsening of diabetes, with minimal side effects 
(Hussein, Abu-Zinadah, 2010; Prabhakar et al., 2012; 
Jeenger et al., 2015).
In this context stands out the curcumin, a yellow-
gold pigment which is the main active extracted from 
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the rhizome of turmeric or saffron (Curcuma longa) 
being such plant traditionally used in Chinese and Indian 
cooking and medicine (Jeenger et al., 2015). Curcumin is 
widely studied for its great antioxidant potential and can 
be used as a dietary supplement to act in the protection of 
biomolecules, being associated with improvements in the 
treatment of several diseases (Anand et al., 2008; Volp, 
Renhe, Stringueta, 2009; Honorato et al., 2013). Despite 
its important pharmacological properties and excellent 
safety profile, curcumin has problems as to its solubility, 
bioavailability and intense color, hindering its widespread 
use (Anand et al., 2007; Prasad, Tyagi, Aggarwal, 2014).
Thus, the search for new compounds displaying 
antioxidant properties and that overcome the problems 
associated with curcumin is of interest for use as a food 
supplement. This type of supplement could be used, for 
example, to reduce damage caused by oxidative stress in 
diabetes (Anand et al., 2008; Bhullar et al., 2013; Jeenger 
et al., 2015). The antioxidant activity in vitro of hydrazine-
thiazole derivatives was described by Shih at al. in 2007, 
with interesting results (Shih, Su, Wu, 2007). According 
to these authors, the scavenging activity of hydrazine-
thiazoles can be related to the presence of N-H group in the 
hydrazine moiety, which has ability to donate a hydrogen 
atom and to reduce the DPPH radical (Figure 1).
Lahsasni et al. (2014) evaluated the antioxidant 
activity of nitrochalcones using the 1,1-biphenyl-2-
picrylhydrazyl (DPPH) free radical scavenging method 
and, among the tested compounds, the (E)-3-(3-(4-
nitrophenyl)-3-oxoprop-1-en-1-yl)phenyl palmitate was 
the most effective, showing higher antioxidant activity 
than the ascorbic acid (Lahsasni, Al Korbi, Aljaber, 
2014). In addition, recently, the antioxidant activity of 
2-substituted-5-nitro-benzimidazole derivatives was 
investigate by Archie et al. (2017) and these compounds 
showed a good activity with IC50 values ranging from 
3.17 to 7.59 µg/mL (Archie et al., 2017) (Figure 2). These 
studies indicate that the presence of a nitro group can be 
important for the antioxidant activity. 
Based on the scavenging ability of hydrazine-
thiazole derivatives and potential biological activity 
displayed by nitro compounds, we decided to synthesize 
a hydrazine-thiazole-nitrocompound (HT-NO2) hybrid and 
to evaluate its antioxidant potential activity (Figure 3). 
FIGURE 1 - Schematic representation of the reaction between DPPH radical and hydrazine-thiazole derivatives.
FIGURE 2 - Examples of nitro compounds with antioxidant activity.
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MATERIAL AND METHODS
Synthesis
Melting point was determined on a Microquímica 
MQAPF 301 apparatus and is uncorrected. A FT-IR 
spectrum was recorded using a Perkin Elmer Spectrum 
One infrared spectrometer and absorption is reported as 
wave numbers (cm-1). NMR spectrum was recorded on a 
BrukerAvance DPX 200 spectrometer (200 MHz). Chemical 
shifts are given in δ (ppm) scale and J values are given in 
Hz. All reagents of analytical grade were obtained from 
commercial suppliers and used without previous purification. 
Synthesis of 2- [(3- nitrophenyl)hydroxy methyl] 
-cyclohexanone 1 (Singh, Pandey, Tripathi, 2008)
A solution of NaOH 0.2 mol/L (1 eq.) was added 
slowly to a mixture of cyclohexanone (2.0 eq.) and 
3-nitrobenzaldehyde (1.0 eq.) and stirred at room 
temperature. The reaction was monitored by TLC (hexane/
ethyl acetate 6:4). After 1 hour, the mixture was diluted 
with cool water and washed with ethyl acetate (3x 30 
mL). The organic layer was dried over anhydrous sodium 
sulfate, filtered and concentrated. The product 1 was 
obtained as a yellow oil in 91% yield. IR (cm-1): 3472, 
3090, 2940, 2865, 1697, 1524, 1347 1480, 1448.
Synthesis of 2-[(3-(nitrophenyl)hydroxymethyl)
cyclohexylidene)hydrazine-carbothioamide 2
Using the general procedure described in literature 
(Maccioni et al., 2002), the thiosemicarbazone 2 was 
obtained as a white solid in 61% yield. Mp: 171.5-174.9 °C; 
IR (cm-1): 3392, 3238, 3153, 3026, 2985, 1603, 1521, 
1346, 1471, 1434.
Synthesis of 2-[(2-(3-nitrophenyl)hydroxymethyl)
cyclohexylidenehydrazo]-4-(4-chlorophenyl)thiazole 
(HT-NO2)
Using the general procedure described in literature 
(Maccioni et al., 2002), HT-NO2 was obtained as an orange 
solid in 99 % yield. Mp: 182.1-182.9 °C; IR (cm-1): 3376, 
3037, 2936, 2857, 1619, 1536, 1348, 1479, 1445, 737; 1H 
NMR (200 MHz, DMSO-d6), δ/ppm: 8.3 (1H, s); 8.2 (1H, 
d); 7.9-7.8 (3H, m); 7.6-7.6 (2H, m); 7.4 (2H, d); 7.3 (1H, 
s); 5.2 (1H, d); 2.6 (2H, m); 1.7-1.2 (8H, m); 13C NMR 
(50 MHz, DMSO-d6), δ/ppm: 169,6, 156.8, 149.3, 147.4, 
143.2, 132.8, 132.5, 132.3, 128.4, 128.1, 126.5, 121.9, 
121.4, 102.7, 74.2, 50.0, 30.0, 26.8, 24.7, 23,7; HRMS 
(m/z) 457.1096 [M+H]+ calcd 457.1101 C22H22ClN4O3S+.
In vitro assays
DPPH radical scavenging assay
The ability of curcumin and HT-NO2 to scavenge 
2,2-diphenyl-1-picrylhyadrazyl (DPPH•) radical was 
measured using the method described by Lue et al. (2010) 
with modifications (Bhullar et al., 2013), on microscale 
and triplicate. The absorbance was measured at 515 nm 
on a spectrophotometer with automatic microplate reader 
(Molecular Devices, VersaMaxProgram, Sunnyvale, 
California, USA) and the percentage of DPPH that has 
reacted was calculated by using Eq. 1:
% antioxidant activity = ((Acontrol- Asample)/Acontrol)*100   (1)
being A = absorbance at 515 nm.
ABTS radical cation scavenging assay
Antioxidant  ac t iv i ty  of  2 ,2-azino-bis- (3-
ethylbenzthiazoline-6-sulfonic acid) (ABTS•+) radical 
capture method was determined by the method described 
by Re et al. (1999) and modified by Dinkova-Kostova 
et al. (2007), on microscale and triplicate, measuring 
the absorbance at 734 nm in a spectrophotometer with 
automatic microplate reader (Molecular Devices, Versa 
Max Program, Sunnyvale, California, USA). The amount 
of radical scavenged by the samples was calculated using 
Eq. 2, and the result was expressed in percentage of 
antioxidant activity:
% antioxidant activity = ((Acontrol- Asample)/Acontrol)*100  (2)
being A = absorbance at 734 nm.
Ferric reducing antioxidant power (FRAP) assay
To assess the antioxidant capacity based on ferric 
reduction, the method described by Benzie and Strain 
(1996) was used with modifications (Bhullar et al., 2013), 
in triplicate. After reading the absorbance at 593 nm in 
a spectrophotometer with automatic microplate reader 
FIGURE 3 - Chemical structure of the hybrid molecule 
synthesized in this work.
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(Molecular Devices, Versa Max Program, Sunnyvale, 
California, USA), the antioxidant potentials of the 
analyzed substances were calculated based on Trolox 
standards at concentrations of 50, 100, 150, 200, 250, 
300 and 350 µM. The results were expressed as Trolox 
equivalentes, or TE, in µM Trolox/ 100 µM sample.
Cytotoxicity against Vero cells
The cytotoxicity of HT-NO2 was tested using healthy 
cells model (Vero cells, isolated from kidney of an African 
green monkey), donated by Dr Erna Kroon (Federal 
University of Minas Gerais, Brazil). The lineage was 
maintained in the logarithmic phase of growth in DMEM 
(Dulbecco’s Modified Eagle Medium, Sigma Aldrich, St. 
Louis, Missouri, USA) supplemented with 100 U mL-1 
penicillin and 100 mg mL-1 streptomycin (GIBCO BRL, 
Grand Island, NY) enriched with 5% of fetal bovine serum 
(GIBCO BRL, Grand Island, NY). Cells were maintained 
at 37 ºC in a humidified incubator with 5% CO2 and 95% 
air. The media were changed twice weekly and they were 
regularly examined.
Cytotoxicity assay was performed using MTT 
to measure cell viability, as previously described 
(Monks et al., 1991). Compound was tested at a range 
of concentrations from 0.1 to 100 μM. Cells were seed 
at density of 10,000 cell/well (96 well-plates, Sarstedt, 
Germany) and pre incubated for 24 hours to allow 
stabilization. Cells were seeded at density of 10,000 
cell/well (96 well-plates, Sarstedt, Germany) and pre 
incubated for 24 hours to allow stabilization. The 
different concentrations of compound was added to cells 
and incubated for 48 hours in an atmosphere of 5% CO2 
and 100% relative humidity. Twenty microliters of MTT 
solution (5 mg.mL-1 in phosphate-buffered saline, Sigma 
Aldrich, St. Louis, Missouri, USA) were added to each well 
4 h before the end of period incubation. The supernatant 
was removed and 200 μL of 0.04 M HCl in isopropyl 
alcohol (Vetec, Brazil) were added to dissolve the formazan 
crystals. The optical densities (OD) were evaluated in a 
spectrophotometer at 595 nm (Molecular Devices, Versa 
Max Program, Sunnyvale, California, USA). Controls 
included drug-containing medium (background) and 
drug-free complete medium. Drug-free complete 
medium was used as control (blank) and was treated in 
the same way as the drug-containing media. Results were 
expressed as percentage of cell proliferation, comparing 
with 0.5% DMSO control and were calculated by Eq. 3:
viability (%) = (mean OD treated – mean OD back-
ground)/ (mean OD untreated cultured, i.e. 0.5% DMSO 
– mean OD blank wells) x 100. (3)
In vivo assays
Animal procedures
Forty-eight male Wistar rats, near 30 days old, 
weighting 80-170 g, were obtained from animal house of 
Faculty of Pharmacy, UFMG. The rats were individually 
housed in a room with monitored temperature (23.6 ± 1.6 
°C) and humidity (61.6 ± 8.4%), with a lighting schedule 
of 12 h light and 12 h dark. Before the experiment, the 
rats were submitted to a period of 12 days of adaptation. 
Diabetes was induced in 40 rats by a single intraperitoneal 
injection of streptozotocin (50 mg/kg body weight). After 
3 days, capillary blood glucose (CBG) was assessed, and 
the animals with fasting glycemia higher than 200 mg/dL 
were considered diabetic, being chosen for the experiment. 
The proposed experimental protocol was prepared 
in compliance with the Ethical Principles of Animal 
Experimentation, and approved by the Ethics Committee 
on Animal Use (CEUA/UFMG) under registration number 
273/2013.
The 48 animals were distributed into six groups of 
8 animals each, as follows:
•	 Control Group: Non-diabetic, vehicle (Carboxy-
methyl cellulose – CMC – 0.5%) by oral gavage;
•	 Diabetic Control Group: Diabetic, CMC 0.5% by 
oral gavage;
•	 Group Curc-50: Diabetic, curcumin 50 mg/kg of 
body weight by oral gavage;
•	 Group Curc-100:Diabetic, curcumin 100 mg/kg of 
body weight by oral gavage;
•	 Group HTNO2-50: Diabetic, HT-NO2 50 mg/kg of 
body weight by oral gavage;
•	 Group HTNO2-100: Diabetic, HT-NO2 100 mg/kg 
of body weight by oral gavage.
A standard pellet diet and tap water were supplied ad 
libitum for all the animals. The oral gavage was performed 
once a day in the morning, for 31 days, using CMC 0.5% 
as vehicle. After that, animals were euthanized, blood was 
collected and liver was dissected out for analyses.
Lipid peroxidation assessment by formation of 
thiobarbituric acid reactive substances (TBARS)
For evaluation of lipid peroxidation, it was used a 
method based on Buege and Aust (1978), on microscale 
and triplicate, by measuring the thiobarbituric acid (TBA) 
reactivity of malondialdehyde (MDA), an end product of 
fatty acid peroxidation (Buege, Aust, 1978). Readings at 
530 nm were performed (Molecular Devices, Versa Max 
Program, Sunnyvale, Califórnia, USA) and a standard 
curve was prepared using MDA. TBARS measure was 
expressed as µM of MDA/ gram of the liver.
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Evaluation of liver antioxidant enzymes activity
Superoxide Dismutase (SOD). SOD activity was 
determined as proposed by Marklund and Marklund 
(1974), with modifications, being measured the inhibition 
of pyrogallol autoxidation (Marklund, Marklund, 1974). 
The assay was performed on microscale and triplicate, 
performing readings at 570 nm (Molecular Devices, Versa 
Max Program, Sunnyvale, Califórnia, USA). The results 
were expressed as units of SOD per miligrams of total 
protein (U SOD/mg total protein).
Catalase (CAT). CAT activity was determined by 
a method based on Aebi (1984) (30), in triplicate (Aebi, 
1984). The difference between 240 nm absorbance 
(Molecular Devices, Versa Max Program, Sunnyvale, 
California, USA) on time 1 minute and time 0 minute give 
the result, expressed as ΔE. Result of CAT activity was 
expressed in arbitrary units, as Eq. 4:
CAT activity= ΔE x min-1 x g-1of total protein (4)
Glutathione Peroxidase (GPx). GPx activity 
was assessed following Flohé e Gunzler (1984) with 
modifications, on microscale and triplicate. Readings were 
performed on time 0 minute and time 1 minute, at 340 nm, 
in a spectrophotometer with automatic microplate reader 
(Molecular Devices, Versa Max Program, Sunnyvale, 
Califórnia, USA). Results were expressed in arbitrary 
units, as Eq. 5:
GPx activity= ΔE x min-1 x g-1of total protein (5)
Glutathione Reductase (GR). GR activity was 
determined by the method described by Carlberg e 
Mannervick (1975) with modifications, on microscale 
and triplicate. Readings were performed on time 0 minute 
and time 1 minute, at 340 nm, in a spectrophotometer with 
automatic microplate reader (Molecular Devices, Versa 
Max Program, Sunnyvale, Califórnia, USA). Results were 
expressed in arbitrary units, as Eq. 6:
GR activity= ΔE x min-1 x mg-1of total protein (6)
Biochemical analysis
Biochemical analysis were performed by means of 
Bioclin® standardized diagnostic kits (Bioclin – Quibasa 
Química BásicaLtda) for spectrophotometric assessments 
(spectrophotometer UV/Vis AJX-1900, Micronal S.A., 
São Paulo, São Paulo, Brazil). The following blood 
biochemical parameters were analyzed: uric acid, 
alanine aminotransaminase (ALT), albumin, amylase, 
aspartate aminotransaminase (AST), total cholesterol, 
creatinine, HDL cholesterol, alkaline phosphatase (ALP), 
hemoglobin, magnesium, total protein, triglycerides and 
urea. Kits were utilized according to manufacturer's 
specifications.
Statistical analyses
After removal of outliers by the Grubbs test, the 
comparison of means was performed by analysis of 
variance (ANOVA), following Tukey’s test. Differences 
were considered significant when the probability was 
P<0.05.
RESULTS AND DISCUSSION
Synthesis
The hydrazine-thiazole TH–NO2 was synthesized 
in three steps as depicted in Scheme 1. All the attempts to 
obtain the product resulting from the aldol condensation 
between cyclohexanone and 3-nitrobenzaldehyde failed, 
even though different temperature conditions were tested. 
In all cases, the only product obtained was the product of 
aldol addition 1, which was then used in the next steps of 
synthesis. The mixture of isomers of 1 was converted to 
the thiosemicarbazone 2 using a classic methodology by 
reacting the ketone with thiosemicarbazide (Maccioni at 
al., 2002). Then, the thiosemicarbazone 2 was subjected 
to a cyclization reaction in the presence of 4-chloro-2’-
bromoacetophenone.
DPPH, ABTS and FRAP assays
In vitro antioxidant activity results are shown in 
Table I. Curcumin and the synthetic antioxidant Trolox 
were used as positive control.
In the DPPH assay for antioxidant activity 
assessment, curcumin showed a lower capability for 
capturing such radical (40.10 ± 1.36%) when compared 
to trolox (47.43 ± 1.48%). The opposite occurred in the 
ABTS assay, in which curcumin (30.18 ± 2.01%) showed 
better results than trolox (19.51 ± 0.98%). In the FRAP 
assay, 100 µM of curcumin was equivalent to 102.55 µM 
of trolox, showing a slightly superior antioxidant capacity 
of curcumin.
In all of these assays, it was observed that HT-NO2 
showed better results than that of the positive control 
(curcumin). Regarding IC50, the hydrazine-thiazole 
derivative showed lower value than that of curcumin 
(IC50 = 167.7 µM), thus being more active: HT-NO2 
(IC50 = 139.2 µM).
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SCHEME 1 - Synthetic route for the preparation of hydrazine-thiazole HT-NO2.
TABLE I - Comparison of the results obtained for the in vitro antioxidant assays: DPPH radical scavenging assay; ABTS radical 
cation scavenging assay and ferric reducing antioxidant power (FRAP) assay
Sample DPPH (%) ABTS (%) FRAP (µM TE/ 100 µM sample)
Curcumin 40.10 ± 1.36 30.18 ± 2.01 102.55 ± 0.80
Trolox 47.43 ± 1.48 19.51 ± 0,98 -
HTNO2 38.91 ± 0.95 18.27 ± 3.09 64.12 ± 2.41
Before the in vivo evaluation, the substance HT-
NO2 was tested for its cytotoxicity against Vero cell 
lines. Vero cell lines are cell lines derived from African 
Green Monkeys and are commonly used to investigate 
the cytotoxicity of the substances against mammalian 
cells (Lavrado et al., 2010). Substance HT-NO2 showed 
no cytotoxicity against Vero cells at 100 µM since no 
reduction on cell viability was observed using MTT 
assay, when compared with the control (DMSO, 0.5%). 
Therefore, it was considered suitable for use in the animal 
model of diabetes mellitus.
Physiological parameters of animals
In vivo studies were conducted using normal rats 
and rats with streptozotocin-induced diabetes. The 
capillary blood glucose of rats was checked weekly, and 
the mean values are presented in Figure 4. Table II shows 
the statistical analysis of glucose levels in the last week 
of the experiment in order to assess the real impact of the 
treatments.
All experimental groups showed initial average 
blood glucose levels within the normal range (around 95 
mg/dL), just as observed by Najafian (2014) and Palma 
et al. (2014). After three days of diabetes induction, the 
groups submitted to STZ administration at the dose of 
50 mg/kg and had a significant increase in blood glucose 
levels (around 480 mg/dL), characterizing them as 
diabetics. Chronic hyperglycemia, a characteristic found 
in diabetic groups treated or not, results from the failure 
in production or effect of insulin, leading to abnormalities 
in carbohydrate, protein and lipid metabolism (Prabhakar 
et al., 2013).
At the end of the experiment, it was observed that 
the glycemia of the non-diabetic control group maintained 
normal levels, in contrast to the diabetic rats, either treated 
or not. Treatments with either curcumin or HT-NO2 showed 
no changes in the altered glycemic profile of diabetic rats. 
Such result may be due in part to the high glycemic rates 
resulting from altered insulin production, whose control 
requires inclusion of insulin in the treatment.
Food intake for each group, as well as the evolution 
of the animals’ body weight, were assessed every three days 
throughout the test. Results are shown in Figures 5 and 6.
Figures analysis showed a significant increase 
in food intake for diabetic mice when compared to the 
control group without diabetes. However, treatments 
with curcumin and HT-NO2 showed no influence on food 
intake when compared to the diabetic animals with no 
treatment. The non-diabetic control group differed from 
others with a greater weight gain, which lasted throughout 
the experimental period. At the end of the experiment, a 
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minor body weight gain was observed in the diabetic rats 
when compared to the control group without diabetes. 
Among the groups treated with curcumin and HT-NO2, 
the animals treated with HT-NO2 at 100 mg/kg showed a 
similar weight gain to the diabetic control group. Animals 
treated with curcumin 50 mg/kg followed by HT-NO2 
50 mg/kg and curcumin 100 mg/kg showed a greater 
weight gain when compared to the diabetic control group, 
showing evidence of a protective role of these substances 
in animals’ weight gain.
Thus, treatment with curcumin and HT-NO2 had 
no influence on animal food intake, but prevented at 
least partially the loss of body weight when compared to 
diabetic animals with no treatment.
Weight loss, which is a characteristic symptom of 
uncontrolled diabetes, and which can be observed from 
the induction model used in this study, may be explained 
by the absence of insulin in DM, compromising glucose 
uptake by cells of the organism, making such carbohydrate 
unavailable for energy gain. Thus, the organism comes into 
a state of high catabolism, leading to degradation or loss 
of structural proteins responsible for rigidity, consistency 
and elasticity of tissues, as well as increased lipolysis, both 
affecting reduction of body weight in DM, together with 
dehydration by polyuria (Sarkhail et al., 2007).
The increase in food intake that occurs in DM 
can be linked to disturbances in the processes of hunger 
regulation in the hypothalamus. After a meal, insulin is 
present at high plasma concentrations, being transported 
across the blood-brain barrier, acting as an anorectic 
agent with action mainly in the arcuate nucleus of the 
hypothalamus, causing satiety. However, in DM, with no 
insulin, the central system is not inhibited and therefore 
indicates a lack of glucose, and hunger, stimulating 
increased food intake (van de Sande-Lee, Velloso, 2012).
In the present study, it was also observed that the 
animals of diabetic groups showed other typical symptoms 
of decompensated DM beyond polyphagia and poliastenia, 
FIGURE 4 - Changes in capillary blood glucose levels of animals throughout the experimental period. Control = control group,non-
diabetic; Diabetic Control = diabetic control group, diabetic; Curc-50 = group Curc-50, diabetic, curcumin 50 mg/kg of body 
weight by oral gavage; Curc-100 = group Curc-100, diabetic,curcumin 100 mg/kg of body weight by oral gavage; HTNO2-50 = 
group HTNO2-50, diabetic, HTNO2 50 mg/kg of body weight by oral gavage; HTNO2-100 = group HTNO2-100, diabetic, HTNO2 
100 mg/kg of body weight by oral gavage.
TABLE II - Capillary blood glucose levels of animals at the end 
of experiment (week 5)
Group Blood glucose (mg/dL) ± S.D.
Control 106.6 ± 6.8 b
DiabeticControl 496.9 ± 102.0 a
Curc-50 499.0 ± 92.4 a
Curc-100 514.9 ± 80.9 a
HTNO2-50 462.2 ± 73.9 a
HTNO2-100 543.7 ± 51.7 a
Mean ± standard deviation followed by different letters in 
the column differ from each other by Tukey’s test, with 95% 
confidence.Control = control group,non-diabetic; Diabetic 
Control = diabetic control group, diabetic; Curc-50 = group 
Curc-50, diabetic, curcumin 50 mg/kg of body weight by oral 
gavage; Curc-100 = group Curc 100, diabetic,curcumin 100 mg/
kg of body weight by oral gavage;HTNO2-50 = group HTNO2-
50, diabetic, HT-50 mg/kg of body weight by oral gavage; 
HTNO2-100 = group HTNO2-100, diabetic, HTNO2 100 mg/kg 
of body weight by oral gavage.
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FIGURE 6 - Animals’ body weight evolution throughout experimental period. Adapt. = Adaptation period, measurement of body 
weight on the indicated days; Diab. Ind. = Diabetes induced period, measurement of body weight on the indicated days; Gav. = Oral 
gavage period, measurement of bodyweight on the indicated days. Control = control group,non-diabetic; Diabetic Control = diabetic 
control group, diabetic; Curc-50 = group Curc-50, diabetic, curcumin 50 mg/kg of body weight by oral gavage; Curc-100 = group 
Curc-100, diabetic, curcumin 100 mg/kg of body weight by oral gavage; HTNO2-50 = group HTNO2-50, diabetic, HTNO2 50 mg/
kg of body weight by oral gavage; HTNO2-100 = group HTNO2-100, diabetic, HTNO2 100 mg/kg of body weight by oral gavage.
FIGURE 5 - Food intake of the animals throughout experimental period. Adapt. = Adaptation period, measurement of food intake 
on the indicated days; Gav. = Oral gavage period, measurement of food intake on the indicated days. Control = control group,non-
diabetic; Diabetic Control = diabetic control group, diabetic; Curc-50 = group Curc-50, diabetic, curcumin 50 mg/kg of body 
weight by oral gavage; Curc-100 = group Curc-100, diabetic, curcumin 100 mg/kg of body weight by oral gavage; HTNO2-50 = 
group HTNO2-50, diabetic, HTNO2 50 mg/kg of body weight by oral gavage; HTNO2-100 = group HTNO2-100, diabetic, HTNO2 
100 mg/kg of body weight by oral gavage.
Assessment of anti-diabetic activity of a novel hydrazine-thiazole derivative: in vitro and in vivo method
Braz. J. Pharm. Sci. 2019;55:e18218 Page 9 / 14
such as polyuria and polydipsia, consistent with symptoms 
found in other experiments that used the same STZ-
induced diabetes model in rats (Najafian, 2014; Gutierres 
et al., 2012). Such symptoms are widely known in DM 
and are related to hyperglycemia, which is the main factor 
responsible for the development of polyuria, polydipsia, 
and polyphagia.
The animals’ liver was removed and its weight 
measured, as shown in Table III. Values are presented as 
percentage of animal’s body weight ± standard deviation, 
followed by a mean comparison test.
It is observed that only the non-diabetic control 
group was statistically different from the others. All 
diabetic groups, both with and without treatment, showed 
an increased ratio of liver to body weight when compared 
to the control group without diabetes. Such fact can 
be explained by the lack of insulin production in this 
experimental model of DM, causing disturbances in the 
metabolism of carbohydrates, proteins, and lipids. In this 
pathogenesis, adipose tissue begins to release stored fat in 
order to be used as energy by the body. Lipids pass through 
the liver, which starts to accumulate an excess of available 
lipids (Sousa, Navarro, 2013).
Thiobarbituric acid reactive substances (TBARS)
Table IV shows the means of each group for TABRS 
carried out in animal liver samples. The values are 
expressed as µM of MDA/gram of the liver ± standard 
deviation, followed by mean comparison test.
Based on the results of this study, changes in levels 
of thiobarbituric acid reactive substances between the 
control and treated groups were not observed. It is known 
that hyperglycemia in DM is responsible for the increased 
production of reactive species, thereby causing oxidative 
stress, which in turn leads to impairment of antioxidant 
defenses and increased susceptibility to lipid peroxidation. 
Although diabetic groups showed high glycemic rates in 
this assessment, increased lipid peroxidation (measured 
by TBARS) was not observed in such groups. Such fact 
can be related to the state of the antioxidant system, which 
played an important role in the elimination of reactive 
species and may have been protecting the body against 
lipid peroxidation during the 31 days of study.
Antioxidant enzyme activity
Results obtained in testing the activity of SOD, CAT, 
GPx, and GR are shown in Table V, followed by ± standard 
deviation and mean comparison test.
Table 5
The assessment of SOD, CAT, GPx, and GR in liver 
tissue revealed that the activity of such enzymes was not 
statistically different between the control groups both 
with and without diabetes. Among the diabetic groups 
treated with curcumin and HT-NO2, the administration 
TABLE III - Mean values for animails liver weight. Data 
compared to total body weight, divided in experimental groups
Group Liver (% of body weight) ± S.D.
Control 3.7 ± 0.2 b
DiabeticControl 4.9 ± 0.7 a
Curc-50 4.9 ± 0.4 a
Curc-100 4.8 ± 0.4 a
HTNO2-50 4.9 ± 0.5 a
HTNO2-100 5.4 ± 0.7 a
Mean ± standard deviation followed by different letters in 
the column differ from each other by Tukey’s test, with 95% 
confidence.Control = control group,non-diabetic; Diabetic 
Control = diabetic control group, diabetic; Curc-50 = group 
Curc-50, diabetic, curcumin 50 mg/kg of body weight by oral 
gavage; Curc-100 = group Curc-100, diabetic, curcumin 100 
mg/kg of body weight by oral gavage; HTNO2-50 = group 
HTNO2-50, diabetic, HTNO2 50 mg/kg of body weight by oral 
gavage; HTNO2-100 = group HTNO2-100, diabetic, HTNO2 
100 mg/kg of body weight by oral gavage.
TABLE IV - Mean values obtained on formation of thiobarbituric 
acid reactive substances (TBARS) assay in liver samples for 
lipid peroxidation assessment
Group TBARS (µM MDA/g liver)
Control 32.7 ± 8.7 a
DiabeticControl 36.4 ± 8.1 a
Curc-50 49.7 ± 13.2 a
Curc-100 44.0 ± 8.1 a
HTNO2-50 48.9 ± 18.4 a
HTNO2-100 52.4 ± 23.8 a
Mean ± standard deviation followed by different letters in 
the column differ from each other by Tukey’s test, with 95% 
confidence.Control = control group,non-diabetic; Diabetic 
Control = diabetic control group, diabetic; Curc-50 = group 
Curc-50, diabetic, curcumin 50 mg/kg of body weight by oral 
gavage; Curc-100 = group Curc-100, diabetic, curcumin 100 mg/
kg of body weight by oral gavage; HTNO2-50 = group HTNO2-
50, diabetic, HTNO2 50 mg/kg of body weight by oral gavage; 
HTNO2-100 = group HTNO2-100, diabetic, HT 100 mg/kg of 
body weight by oral gavage.
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of HT-NO2 at 100 mg/kg provided high levels of SOD, 
CAT, and GR, which did not differ statistically from 
the other diabetic groups, but differed from the control 
group without diabetes. Regarding the levels of GPx, 
there was no difference between the control groups both 
with and without diabetes and the groups treated with 
curcumin and HT-NO2. Only the Curc-50 and HTNO2-50 
groups were statistically different from each other, the 
former presenting a higher value (1.06 ± 0.18 ΔE.min-1.
mg-1 protein) than the latter (0.44-± 0.20 ΔE.min-1.mg-1 
protein). Thus, the enzyme levels in the liver presented no 
decrease in diabetes, and treatment with curcumin did not 
exert statistically proven effects on the studied enzymatic 
activity rates.
The effect of diabetes on enzyme activity may vary 
according to sex, animal species, time in which the animals 
remained diabetic, or studied tissue, being this activity 
increased, decreased, or unchanged (Martim, Sanders, 
Watkins, 2003). However, the connection between altered 
antioxidant enzymes and increased oxidative stress is 
not straightforward, as changes (increase or decrease) 
in the activities of antioxidant enzymes are not always 
unidirectional (Suryanarayana et al., 2007).
In general, regarding the treatments with curcumin 
and HT-NO2 in this work, no different effects were 
observed when analyzing the activity of liver enzymes 
after 31 days of administration of the substances, despite 
there being a clear tendency of increasing the concentration 
of such enzymes.
The apparent discrepancy between the studied 
molecules’ considerable antioxidant activity detected in 
vitro and no change in liver enzymes and lipid peroxidation 
test, used as indicators of antioxidant activity in vivo, may 
be due to the fact that each individual responds in a unique 
way to stimuli to which it is submitted, and there may be a 
wide variation in individual response. While it is possible 
to exercise control over the vast majority of variables 
involved in an in vitro test, the same does not occur with 
the animal testing where each individual shows itself as a 
complex web of variables dependent on the particularities 
of each one.
Biochemical parameters
A total of 14 biochemical assays were performed in 
animal blood samples. A statistical difference in uric acid 
values between the control group and the HTNO2-100 
group; alkaline phosphatase (ALP) among the control 
group, the diabetic control group, and the CURC-100 
group; alanine aminotransaminase (ALT) and urea 
between the control group and the diabetic control group. 
The mean values found are presented in Table VI, followed 
by ± standard deviation and mean comparison test.
Uric acid, the final product of purine metabolism, 
is formed in the liver and excreted by the kidneys, and 
its blood level elevation may be an indicator of kidney 
disease, DM, cardiovascular disease, or inflammation. 
However, the level of this marker was not found 
statistically increased in the diabetic control group when 
compared to the control group without diabetes.
The parameters AST, ALT, and ALP are considered 
to be markers of liver function and elevated serum levels of 
such enzymes have been reported in diabetic animals, being 
reduced after treatment with insulin (Palma et al., 2014). 
TABLE V - Evaluation of liver enzymes activity – SOD, CAT, GPx, GR
Assay Control Diabetic Control Curc-50 Curc-100 HTNO2-50 HTNO2-100
SOD (U SOD/mg total 
protein)
25.4 ± 6.7 b 34.5 ± 6.9 ab 35.5 ± 6.2 ab 51.3 ± 25.7 ab 29.3 ± 1.8 ab 54.2 ± 24.4 a
CAT (ΔE.min-1.mg-1 
total protein)
0.3 ± 0.1 b 0.5 ± 0.1 ab 0.5 ± 0.1 ab 0.7 ± 0.4 ab 0.4 ± 0.0 ab 0.7 ± 0.4 a
GPx (ΔE.min-1.mg-1 
total protein)
0.7 ± 0.2 ab 0.6 ± 0.3 ab 0.4 ± 0.2 b 0.6 ± 0.2 ab 1.1 ± 0.2 a 0.8 ± 0.5 ab
GR (ΔE.min-1.mg-1 
total protein)
2.1 ± 0.6 b 2.6 ± 0.4 ab 3.1 ± 0.4 ab 4.6 ± 2.1 ab 2.8 ± 0.2 ab 5.1 ± 2.7 a
Mean ± standard deviation followed by different letters in the column differ from each other by Tukey’s test, with 95% confidence.
SOD = superoxide dismutase; CAT = catalase; GPx = glutathione peroxidase; GR = glutathione reductase.Control = control 
group,non-diabetic; Diabetic Control = diabetic control group, diabetic; Curc-50 = group Curc-50, diabetic, curcumin 50 mg/kg of 
body weight by oral gavage; Curc-100 = group Curc-100, diabetic, curcumin 100 mg/kg of body weight by oral gavage; HTNO2-50 
= group HTNO2-50, diabetic, HTNO2 50 mg/kg of body weight by oral gavage; HTNO2-100 = group HT-100, diabetic, HTNO2 
100 mg/kg of body weight by oral gavage.
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AST is widely present in the heart, liver, skeletal muscles, 
and kidneys; ALT is found in a number of different tissues, 
with liver being the main one; and FA isoforms found 
in blood are originated mostly from the liver or skeletal 
muscle. Thus, injuries or disorders which entail cellular 
damage in the liver can result in the release of such enzymes 
into the bloodstream, acting as a marker of hepatocellular 
injury (Prabhakar et al., 2013; Gutierres et al., 2012). In 
this work, no significant difference was found between 
the groups regarding AST levels. ALT and FA rates were 
higher in the diabetic control group when compared to 
the control group without diabetes, corroborating several 
studies showing association of DM with increased activity 
of liver enzymes (Hussein, Abu-Zinadah, 2010; Palma et 
al., 2014; Gutierres et al., 2012). Regarding the FA enzyme, 
diabetic groups treated with curcumin or HT-NO2 showed 
no protective effect on the liver. However, with regard 
to ALT, treatment with curcumin 50, curcumin 100, and 
HTNO2-50 showed statistically similar levels to those of 
the control group without diabetes, which may provide 
evidence of a partial protective action of these substances 
in the liver based on the assessment of such enzyme.
Urea and creatinine parameters were used for 
evaluation of the renal function of the animals. Urea is a 
waste product of protein digestion formed in the liver, and 
creatinine is a residue of creatine phosphate metabolism 
by skeletal muscle tissues, both filtered in the kidneys 
(Prabhakar et al., 2013). Assessed urea rates were higher 
in diabetic animal groups when compared to the control 
group without diabetes; however, it was observed that the 
CURC-50 and HTNO2-50 groups were not statistically 
different from the control group without diabetes, 
suggesting the protection of the renal function in these 
two groups. Regarding the level of creatinine, there was 
no significant difference between the groups.
Since in diabetic conditions protein synthesis is 
decreased in all tissues and muscle proteolytic activity 
is increased, there is a greater influx of amino acids to 
the liver, raising serum levels of nitrogenous compounds 
such as urea and creatine and increasing renal work 
excretion (Prabhakar et al., 2013). In this study, statistical 
differences were evident in urea levels, but not creatinine, 
which may be related to the trial period since urea is more 
responsive to primary changes in renal conditions (Prates 
et al., 2007).
Although DM is frequently associated with 
dyslipidemia, with high levels of total cholesterol, LDL, 
and triacylglycerols, and low levels of HDL, there were 
TABLE VI - Results of biochemical assays ofratsblood samples
Assay Control Diabetic Control Curc-50 Curc-100 HTNO2-50 HTNO2-100
Uricacid (mg/dL) 0.8 ± 0.2 b 1.8 ± 1,0 ab 1.2 ± 0.4 ab 1.0 ± 0.1 ab 0.8 ± 0.2 ab 1.8 ± 1.1 a
ALP (U/L) 87.5 ± 5.8 c 280.5 ± 44.9 b 236.1 ± 104.1 b 402.8 ± 31.3 a 304.2 ± 29.8 b 304.9 ± 62.2 b
ALT (U/mL) 72.0 ± 27.2 b 147.9 ± 43.6 a 111.4 ± 15.5 ab 99.3 ± 14.1 ab 99.3 ± 42.1 ab 131.2 ± 29.2 a
Urea (mg/dL) 35.2 ± 3.9 b 71.3 ± 27.2 a 65.6 ± 21.9 ab 71.7 ± 20.4 a 54.2 ± 5.5 ab 74.2 ± 13.6 a
Albumin (g/dL) 2.3 ± 0.1 a 2.0 ± 0.2 a 2.3 ± 0.2 a 2.31 ± 0.2 a 2.4 ± 0.2 a 2.3 ± 0.2 a
Amylase (U/dL) 708.9 ± 23.8 a 711.8 ± 20.2 a 704.8 ± 3.2 a 694.4 ± 23.0 a 698.4 ± 21.7 a 701.3 ± 4.6 a
Total cholesterol (mg/dL) 105.3 ± 21.3 a 93.5 ± 16.2 a 106.7 ± 13.3 a 92.1 ± 12.2 a 86.2 ± 9.5 a 107.8 ± 21.4 a
HDL cholesterol (mg/dL) 88.9 ± 20.3 a 71.5 ± 12.5 a 88.5 ± 12.7 a 73.8 ± 5.1 a 73.7 ± 6.1 a 80.6 ± 9.7 a
Creatinine (mg/dL) 0.4 ± 0.0 a 0.4 ± 0.1 a 0.4 ± 0.0 a 0.4 ± 0.1 a 0.4 ± 0,0 a 0.4 ± 0.1 a
Hemoglobin (g/dL) 16.4 ± 1.8 a 14.3 ± 1.7 a 16.3 ± 1.6 a 16.1 ± 0.8 a 15.5 ± 1.1 a 15.4 ± 1.4 a
Magnesium (mg/dL) 2.5 ± 0.3 a 2.9 ± 1.0 a 2.1 ± 0.1 a 2.2 ± 0.2 a 2.1 ± 0.1 a 2.7 ± 0.8 a
Total protein (g/dL) 5.9 ± 0.3 a 5.7 ± 0.3 a 5.6 ± 0.4 a 5.5 ± 0.3 a 5.5 ± 0.1 a 5.6 ± 0.2 a
AST (U/mL) 149.5 ± 47.1 a 179.9 ± 10.4 a 171.3 ± 19.4 a 156.9 ± 15.8 a 133.1 ± 44.2 a 160.7 ± 27.1 a
Triglycerides (mg/dL) 107.8 ± 60.2 a 63.5 ± 27.1 a 94.6 ± 43.2 a 112.9 ± 47.0 a 72.6 ± 19.3 a 98.5 ± 48.5 a
Mean ± standard deviation followed by different letters in the column differ from each other by Tukey’s test, with 95% confidence.
ALP = alkaline phosphatase; ALT = alanine aminotransaminase; AST = aspartate aminotransaminase. Control = control group,non-
diabetic; Diabetic Control = diabetic control group, diabetic; Curc-50 = group Curc-50, diabetic, curcumin 50 mg/kg of body 
weight by oral gavage; Curc-100 = group Curc-100, diabetic, curcumin 100 mg/kg of body weight by oral gavage; HTNO2-50 = 
group HTNO2-50, diabetic, HTNO2 50mg/kg of body weight by oral gavage; HTNO2-100 = group HTNO2-100, diabetic, HTNO2 
100 mg/kg of body weight by oral gavage.
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no statistical differences between the groups regarding 
serum levels of total cholesterol, HDL cholesterol, and 
triacylglycerols.
This study found no significant differences in 
albumin and total protein levels (indicator of alteration 
in protein metabolism or renal dysfunction), amylase 
(indicator of pancreatic disease or renal dysfunction), 
hemoglobin (indicative of anemia, a common disease in 
patients with DM) and magnesium (lower rates associated 
with DM).
It was observed then, in this study, alteration caused 
by DM in hepatocellular injury markers (ALT and ALP) 
and renal function (urea, more sensitive to primary 
alterations of the kidneys, and uric acid). Treatments 
with curcumin 50 and HTNO2-50 showed similar results 
to those of animals without diabetes for ALT and urea 
parameters, suggesting a partial protective action of these 
substances in the liver and kidney of diabetic animals.
CONCLUSION
Evaluation of in vitro antioxidant activity of TH-NO2 
showed superior activity to that of curcumin. Overall, in 
this study it was observed that treatment with curcumin 
and HT-NO2 showed no effects on analyzed liver enzymes, 
although there was a clear trend to increase activity of 
such enzymes in the treated groups. Similarly, no changes 
were detected in lipid peroxidation when assessed after 
treatment of animals with tested substances. It should be 
pointed out, however, that statistically significant changes 
were also not detected in both parameters when comparing 
control groups with and without diabetes, showing that 
perhaps those systems were not altered in this study model.
Evaluation of blood biochemical parameters, 
moreover, allowed the observation that the treatments 
with curcumin and HT-NO2, both at 50 mg/kg, suggest 
a partial protective effect of these substances in the liver 
and kidney of diabetic animals, also demonstrating the 
in vivo antioxidant potential of this class of substances. 
This highlights its promising action toward diabetes-
related complications, opening doors for new studies to 
be conducted.
In addition, the protective role of this substance in 
vivo, demonstrated by blood biochemical parameters, 
indicates that its antioxidant activity may be related to 
routes other than that of liver enzymes, indicating the need 
for further studies.
ACKNOWLEDGEMENTS
We are grateful to Fundação de Amparo à Pesquisa 
de Minas Gerais (FAPEMIG) and Conselho Nacional 
de Desenvolvimento Científico e Tecnológico (CNPq) 
for financial support. We thank Carlos Zani and Markus 
Kohlhoff at the Rene Rachou Institute (Fiocruz Minas) for 
HRMS spectra acquisition.
REFERENCES
Aebi, H. Catalase in vitro. Methods Enzymol. 1984;105:121-6.
Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. 
Bioavailability of curcumin: problems and promises. Mol 
Pharm. 2007;4(6):807-18.
Anand P, Thomas SG, Kunnumakkara AB, Sundaram C, 
Harikumar KB, Sung B, et al. Biological activities of curcumin 
and its analogues (Congeners) made by man and Mother Nature. 
Biochem Pharmacol. 2008;76(11):1590-1611.
Archie SR, Das, BK, Hossain, MS, Kumar U, Rouf ASS. 
Synthesis and antioxidant activity of 2-substituted-5-
nitrobenzimidazole derivatives. Int J Pharm Pharm Sci. 
2017;9(1):308-310. 
Benzie IFF, Strain JJ. The ferric reducing ability of plasma 
(FRAP) as a measure of “antioxidant power”: the FRAP assay. 
Anal Biochem. 1996;239(1):70-6. 
Bhullar KS, Jha A, Youssef D, Rupasinghe HPV. Curcumin 
and its carbocyclic analogs: structure-activity in relation to 
antioxidant and selected biological properties. Molecules. 
2013;18(5):5389-404. 
Buege JA, Aust SD. Microsomal lipid peroxidation. Methods 
Enzymol. 1978;52:302-10.
Carlberg I, Mannervik B. Purification and characterization of the 
flavoenzyme glutathione reductase from rat liver. J Biol Chem. 
1975;250(14):5475-80.
Carocho M, Ferreira ICFR. A review on antioxidants, 
prooxidants and related controversy: Natural and synthetic 
compounds, screening and analysis methodologies and future 
perspectives. Food Chem Toxicol. 2013;51:15-25.
Dinkova-Kostova AT, Cheah J, Samouilov A, Zweier JL, Bozak 
RE, Hicks RJ, et al. Phenolic Michael reaction acceptors: 
combined direct and indirect antioxidant defenses against 
electrophiles and oxidants. Med Chem. 2007;3(3):261-8.
Assessment of anti-diabetic activity of a novel hydrazine-thiazole derivative: in vitro and in vivo method
Braz. J. Pharm. Sci. 2019;55:e18218 Page 13 / 14
Flohé L, Günzler WA. Assays of glutathione peroxidase. 
Methods Enzymol. 1984;105:114-21.
Gutierres VO, Pinheiro CM, Assis RP, Vendramini RC, 
Pepato MT, Brunetti IL, et al. Curcumin-supplemented 
yoghurt improves physiological and biochemical markers of 
experimental diabetes. Br J Nutr. 2012;108(3):440-8. 
Henriques GS, Lopes CVA, Simeone MLF, Binda CC. 
Application of glycemic index method in a rat model: 
standardization using enteral diet for normal animals and 
diabetic ones made by streptozotocin administration. Rev Med 
Res. 2010;12(2):67-78.
Honorato TC, Batista E, Nascimento KO, Pires T. Food 
additives: applications and toxicology. Revista Verde. 
2013;8(5):01-11.
Hussein HK, Abu-Zinadah OA. Antioxidant effect of curcumin 
extracts in induced diabetic Wister rats. Int J Zoo Res. 
2010;6(4):266-276.
Jeenger MK, Shrivastava S, Yerra VG, Naidu V, Sistla R, 
Kumar A, Curcumin: A pleiotropic phytonutrient in diabetic 
complications. Nutrition. 2015;31(2):276-82.
Lahsasni SA, Al Korbi FH, Aljaber NAA. Synthesis, 
characterization and evaluation of antioxidant activities of 
some novel chalcones analogues. Chem Cent J. 2014;8(32):1-10. 
Lavrado J, Reszka AP, Moreira R, Neidle S, Paulo A. C-11 
diamino cryptolepine derivatives NSC748392, NSC748393, and 
NSC748394: anticancer profile and G-quadruplex stabilization. 
Bioorg Med Chem Lett. 2010;20(23):7042-5. 
Lue B, Nielsen NS, Jacobsen C, Hellgren L, Guo Z, Xu X. 
Antioxidant properties of modified rutin esters by DPPH, 
reducing power, iron chelation and human low density 
lipoprotein assays. Food Chem. 2010;123(2):221-30. 
Maccioni E, Cardia MC, Bonsignore L, Plumitallo A, Pellerano 
ML, De Logu A. Synthesis and anti-microbial activity of 
isothiosemicarbazones and cyclic analogues. Farmaco. 
2002;57(10):809-17.
Maritim AC, Sanders RA, Watkins JB. Effects of α-lipoic acid 
onbiomarkers of oxidative stress in streptozotocin-induced 
diabetic rats. J Nutr Biochem. 2003;14(5):288-94. 
Marklund S, Marklund G. Involvement of the superoxide anion 
radical in the autoxidation of pyrogallol and a convenient assay 
for superoxide dismutase. Eur J Biochem. 1974;47(3):469-74.
Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica 
D, et al. Feasibility of a high-flux anticancer drug screen using a 
diverse panel of cultured human tumor cell lines. J Natl Cancer 
Inst. 1991;83(11):757-66.
Prabhakar PK, Prasad R, Ali S, Doble M. Synergistic 
interaction of ferulic acid with commercial hypoglycemic 
drugs in streptozotocin induced diabetic rats. Phytomedicine. 
2013;20(6):488-494. 
Najafian M. Effect of curcumin on metabolism of lipids in 
streptozotocin indiced diabetic an normal rats. Adv Environ 
Biol. 2014;8(12):170-7.
Palma HE, Wolkmer P, Gallio M, Corrêa MM, Schmatz R, 
Thomé GR, et al. Oxidative stress parameters in blood, liver, 
and kidney of diabetic rats treated with curcumin and/or insulin. 
Mol Cell Biochem. 2014;386(1-2):199-210. 
Prasad S, Tyagi AK, Aggarwal BB. Recent developments 
in delivery, bioavailability, absorption and metabolism of 
curcumin: the golden pigment from golden spice. Cancer Res 
Treat. 2014;46(1):2-18.
Prates AB, Amaral FB, Vacaro MZ, Gross JL, Camargo JL, 
Silveiro SP. Glomerular filtration evaluation employing serum 
cystatin C measurement. J Bras Nefrol. 2007;29(1):48-55.
Rani V, Deep G, Singh RK, Palle K, Yadav UCS. Oxidative 
stress and metabolic disorders: Pathogenesis and therapeutic 
strategies. Life Sci. 2016;148(1):183-193.
Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-
Evans C. Antioxidant activity applying an improved ABTS 
radical cation decolorization assay. Free Radic Biol Med. 
1999;26(9-10):1231-7. 
Sarkhail P, Rahmanipour S, Fadyevatan S, Mohammadirad 
A, Dehghan G, Amin G, et al. Antidiabetic effect of Phlomis 
anisodonta: effects on hepatic cells lipid peroxidation and 
antioxidant enzymes in experimental diabetes. Pharmacol Res. 
2007;56(3):261-6. 
M. F. Resende, C. I. Lino, E. M. Souza-Fagundes, J. V. P. Rettore, R. B. Oliveira, R. A. Labanca
Braz. J. Pharm. Sci. 2019;55:e18218Page 14 / 14
Shih MH, Su YS, Wu CL. Syntheses of aromatic substituted 
hydrazino-thiazole derivatives to clarify structural 
characterization and antioxidant activity between 3-arylsydnonyl 
and aryl substituted hydrazino-thiazoles. Chem Pharm Bull. 
2007;55(8):1126-35.
Singh N, Pandey J, Tripathi RP. D-glucosamine, a natural 
aminosugar as organocatalyst for an ecofriendly direct aldol 
reaction of ketones with aromatic aldehydes in water. Catal 
Commun. 2008;9(5):743-746. 
Sousa RAL, Navarro F. Brief report of type ii diabetes and its 
relationship to lipid metabolism, the resistant exercise and the 
effects of this: breaking dogmas. RBPFEX. 2013;7(42):489-500. 
Suryanarayana P, Satyanarayana A, Balakrishna N, Kumar PU, 
Reddy GB. Effect of turmeric and curcumin on oxidative stress 
and antioxidant enzymes in streptozotocin-induced diabetic rat. 
Med Sci Monit. 2007;13(12):286-92.
van de Sande-Lee S, Velloso LA. Hypothalamic dysfunction in 
obesity. Arq Bras Endocrinol Metab [online]. 2012;56(6):341-
50.
Volp ACP, Renhe IRT, Stringueta PC. Bioative natural pigments. 
Alim Nutr. 2009;20(1):157-166. 
World Health Organization. WHO. 2016. Available from: http://
www.who.int/mediacentre/factsheets/fs312/en/.
Yadav SK, Sah AK, Jha RK, Sah P, Shah DK, et al. Turmeric 
(curcumin) remedies gastroprotective action. Pharmacogn Rev. 
2013;7(13):42-46.
Received for publication on 21st March 2018
Accepted for publication on 28th May 2018
This is an open-access article distributed under the terms of the Creative Commons Attribution License.
